The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt ...

UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years ...

The top line of UnitedHealthcare, the company's insurance and managed care business, rose 6.1% to $74.1 billion. Analysts had been looking for $75.22 billion. Revenue from Optum, its ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Company shares soared Friday after leaders told analysts they have made progress improving one of the biggest concerns facing the industry, shrinking prescription reimbursement, and said their ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company. The U.S ...

FactSet's high client retention rate and diverse revenue streams make it a strong buy, despite its high valuation. Recent product expansions, including GenAI solutions and IRN 2.0, enhance FactSet ...

On Thursday, FactSet Research Systems Inc (NYSE: FDS) reported first-quarter 2025 sales growth of 4.9% year-on-year to $568.7 million, beating the analyst consensus estimate of $565.13 million.

If you click on links we provide, we may receive compensation. The best Medicare Advantage provider for 2025 is Cigna, thanks to its low costs and excellent member experience. Kaiser Permanente ...